Log in

NYSE:CRYCryolife Stock Price, Forecast & News

$18.25
-0.01 (-0.05 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$17.94
Now: $18.25
$18.52
50-Day Range
$18.08
MA: $21.49
$25.24
52-Week Range
$12.63
Now: $18.25
$33.00
Volume278,000 shs
Average Volume316,482 shs
Market Capitalization$688.76 million
P/E RatioN/A
Dividend YieldN/A
Beta1.37
CryoLife, Inc., together with its subsidiaries, manufactures, processes, and distributes medical devices and implantable human tissues for use in cardiac and vascular surgeries worldwide. The company operates in two segments, Medical Devices and Preservation Services. It offers BioGlue, an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X mechanical heart valves for aortic and mitral indications; cardiac preservation services; PhotoFix, a bovine pericardial patch for use in cardiac and vascular repairing activities; and PerClot, an absorbable powdered hemostat for use in surgical procedures, including cardiac, vascular, orthopedic, neurological, gynecological, ENT, and trauma surgeries. The company also provides cardiac laser therapy products, which include laser consoles, related service and maintenance, and single-use, as well as fiber-optic hand-pieces for the treatment of coronary artery disease in patients with severe angina. In addition, it distributes E-vita OPEN PLUS, a hybrid stent graft system for the surgical and endovascular treatment; E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac, a stent graft used to treat aneurysmal iliac arteries, as well as aneurysmal iliac side branches; E-vita THORACIC 3G, a stent graft system for the endovascular treatment of thoracic aortic aneurysms; and E-tegra, an abdominal aortic aneurysms stent graft system for the endovascular treatment. Further, the company offers vascular preservation services; and synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures. The company serves physicians, hospitals, and other healthcare industries, as well as cardiac, vascular, thoracic, and general surgeons. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.
Read More
Cryolife logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.57 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP22890310
Phone770-419-3355

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$276.22 million
Cash Flow$0.80 per share
Book Value$7.62 per share

Profitability

Net Income$1.72 million

Miscellaneous

Employees1,200
Market Cap$688.76 million
Next Earnings Date8/4/2020 (Estimated)
OptionableOptionable

Receive CRY News and Ratings via Email

Sign-up to receive the latest news and ratings for CRY and its competitors with MarketBeat's FREE daily newsletter.

Cryolife (NYSE:CRY) Frequently Asked Questions

How has Cryolife's stock been impacted by COVID-19 (Coronavirus)?

Cryolife's stock was trading at $23.87 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CRY shares have decreased by 23.5% and is now trading at $18.25. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Cryolife?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cryolife in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Cryolife.

When is Cryolife's next earnings date?

Cryolife is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Cryolife.

How were Cryolife's earnings last quarter?

Cryolife Inc (NYSE:CRY) announced its quarterly earnings data on Thursday, April, 30th. The medical equipment provider reported ($0.08) earnings per share for the quarter, missing the consensus estimate of $0.02 by $0.10. The medical equipment provider had revenue of $66.43 million for the quarter, compared to analyst estimates of $66.11 million. Cryolife had a positive return on equity of 2.55% and a negative net margin of 1.69%. Cryolife's revenue was down 1.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.04 earnings per share. View Cryolife's earnings history.

What price target have analysts set for CRY?

5 analysts have issued 12 month price targets for Cryolife's shares. Their forecasts range from $25.00 to $29.00. On average, they expect Cryolife's share price to reach $27.50 in the next year. This suggests a possible upside of 50.7% from the stock's current price. View analysts' price targets for Cryolife.

Has Cryolife been receiving favorable news coverage?

Media headlines about CRY stock have been trending somewhat negative recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cryolife earned a coverage optimism score of -1.8 on InfoTrie's scale. They also assigned news coverage about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about Cryolife.

Who are some of Cryolife's key competitors?

What other stocks do shareholders of Cryolife own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryolife investors own include Energy Transfer LP Unit (ET), AT&T (T), Gilead Sciences (GILD), Enterprise Products Partners (EPD), Netflix (NFLX), NVIDIA (NVDA), Teva Pharmaceutical Industries (TEVA), Zoetis (ZTS), Ares Capital (ARCC) and Alibaba Group (BABA).

Who are Cryolife's key executives?

Cryolife's management team includes the following people:
  • Mr. James Patrick MacKin, Chairman, Pres & CEO (Age 52)
  • Mr. David Ashley Lee CPA, CPA, Exec. VP, COO & CFO (Age 54)
  • Ms. Jean F. Holloway, Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec. (Age 62)
  • Mr. John E. Davis, Sr. VP of Global Sales & Marketing (Age 54)
  • Ms. Amy D. Horton CPA, CPA, VP & Chief Accounting Officer (Age 49)

What is Cryolife's stock symbol?

Cryolife trades on the New York Stock Exchange (NYSE) under the ticker symbol "CRY."

How do I buy shares of Cryolife?

Shares of CRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cryolife's stock price today?

One share of CRY stock can currently be purchased for approximately $18.25.

How big of a company is Cryolife?

Cryolife has a market capitalization of $688.76 million and generates $276.22 million in revenue each year. The medical equipment provider earns $1.72 million in net income (profit) each year or $0.31 on an earnings per share basis. Cryolife employs 1,200 workers across the globe.

What is Cryolife's official website?

The official website for Cryolife is www.cryolife.com.

How can I contact Cryolife?

Cryolife's mailing address is 1655 Roberts Boulevard N.W, Kennesaw GA, 30144. The medical equipment provider can be reached via phone at 770-419-3355 or via email at [email protected]

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.